#Best bioanalytical company

[lambdatherapeutic]

Lambda offers a one stop solution for Biosimilar studies. offers high quality and accurate Best Bioanalytical Labs in India. Lambda' Bioavailability/Bioequivalence Studies offer global access to 800+ clinical beds inclusive of 85+ specialized beds designed for specific studies.

[clinfinitesolution1]

Best CRO Companies in Hyderabad

Introduction

Hyderabad has emerged as a major hub for Contract Research Organizations (CROs), offering cutting-edge research and development services to the pharmaceutical and biotech industries. With its strong infrastructure, skilled workforce, and favorable government policies, Hyderabad has become a preferred destination for CRO companies that support drug discovery, clinical trials, and regulatory compliance.

Understanding CROs and Their Role

Contract Research Organizations (CROs) play a crucial role in pharmaceutical research by assisting companies in conducting clinical trials, preclinical research, and regulatory affairs. These organizations help pharmaceutical firms bring new drugs to market efficiently by handling complex research processes, ensuring compliance with regulatory guidelines, and reducing development costs. The services offered by CROs range from early-stage drug discovery to post-marketing surveillance, making them vital players in the healthcare and life sciences industries.

Why Hyderabad is a Hub for CRO Companies

Hyderabad, often referred to as the ‘Genome Valley of India,’ has become a hotspot for pharmaceutical and biotech research. The city boasts state-of-the-art laboratories, research parks, and biotechnology clusters that attract global pharmaceutical giants. Additionally, Hyderabad is home to renowned research institutions, universities, and a skilled talent pool, making it an ideal location for CRO companies. The Indian government’s proactive support, including tax incentives and funding initiatives, further strengthens Hyderabad’s position as a leading CRO destination.

Leading CRO Companies in Hyderabad

Several CRO companies in Hyderabad are renowned for their expertise in clinical research, bioanalytical testing, and regulatory affairs. Some of the top players in the industry include:

Syngene International – A leading CRO specializing in drug discovery, development, and manufacturing solutions.

GVK BIO (Aragen Life Sciences) – Offers integrated research services across the drug development spectrum.

Sai Life Sciences – Focuses on preclinical and clinical research for global pharmaceutical companies.

Parexel – A global CRO with a strong presence in Hyderabad, providing clinical trial management and regulatory support.

These companies contribute significantly to drug development by ensuring the safety, efficacy, and compliance of new pharmaceutical products.

Services Offered by CRO Companies in Hyderabad

CROs in Hyderabad provide a comprehensive range of services tailored to the needs of pharmaceutical and biotech companies. Some key services include:

Preclinical Research – Laboratory testing to evaluate the safety and effectiveness of new drug compounds.

Clinical Trials – Conducting Phase I-IV trials to assess drug safety and efficacy before regulatory approval.

Regulatory Affairs – Assisting with documentation, submission, and compliance with global regulatory authorities.

Bioanalytical Testing – Quality control and analytical testing to ensure drug consistency and purity.

These services help pharmaceutical companies streamline the drug development process while maintaining high standards of research and compliance.

Factors to Consider When Choosing a CRO in Hyderabad

Selecting the right CRO is critical for the success of a research project or clinical trial. Companies should consider the following factors when choosing a CRO in Hyderabad:

Experience & Expertise – A well-established CRO with a strong track record in the industry.

Regulatory Compliance – Adherence to international guidelines such as FDA, ICH, and GCP standards.

Technology & Infrastructure – Availability of advanced laboratories, equipment, and research facilities.

Client Reviews & Success Stories – Positive testimonials and proven success in delivering results.

By carefully evaluating these factors, pharmaceutical companies can partner with the right CRO to accelerate their drug development process.

Growth and Future Prospects of the CRO Industry in Hyderabad

The CRO industry in Hyderabad is poised for significant growth as global pharmaceutical companies continue to outsource research and development to India. With increasing investments in biotechnology, government support, and advancements in medical research, CRO companies in Hyderabad are expected to expand their capabilities and strengthen their global presence. This growth will not only benefit the pharmaceutical industry but also create employment opportunities and drive innovation in healthcare research.

Conclusion

Hyderabad continues to solidify its reputation as a premier destination for CRO services, offering world-class research and development support to pharmaceutical and biotech companies. With a strong ecosystem, skilled professionals, and a growing demand for drug innovation, CRO companies in Hyderabad are playing a crucial role in shaping the future of global healthcare.

[amitynoida]

Amity University: Leading Among the Colleges Providing B.Sc. Bioinformatics Course in Noida

B.Sc. Bioinformatics is a modern, interdisciplinary field of education that seeks to curate methods and online tools for understanding biological data, particularly in large data sets. It is a concept that combines biology, physics, chemistry, computer science, mathematics, statistics, and information engineering.

Amity Noida is on a lead among the best university that are providing B.Sc. Bioinformatics course in Noida. Designed in accordance with international standards the course focuses on proving a comprehensive approach to its learners on developing modern medicines and new agricultural products. Being among the best Bioinformatics colleges in Delhi NCR the university focuses its applications in genome profiling, genome sequencing, and protein expression analysis.

Infrastructure

Amity University is equipped with 100 Mbps Wi-Fi at every corner, computer labs, libraries, CCTV coverage all around the campus, audio-visual facilities, A/C classrooms, a high-end conference hall, printing facilities, all possible lab facilities for the B.Sc. students with the faculty support and practical exposure.

Amity:  Best Bioinformatics University in Delhi NCR

Amity University is one of the best Bioinformatics colleges in Delhi NCR. It aims to increase the student's understanding of Biological Processes. Bioinformatics is mainly used to extract knowledge from biological data through the development of algorithms and software. It is widely applied in the examination of Genomics, Proteomics, 3D structures modeling of proteins, image analysis, drug designing, and a lot more.

Duration and Eligibility

The duration of B.Sc. Bioinformatics course at Amity University is 4 years and the students who have scored 60% in 10th standard and 12th standard and 60% in PCM/PCB are eligible to apply for the course.

Career Opportunities

Amity being among the best Bioinformatics colleges in Delhi NCR understands the need of the hour and the importance of growth in the scientific field offering promising career opportunities. The university provides campus placements where students can work in leading IT companies. Candidates can pursue careers in computational chemistry, bioanalytics, database design and maintenance, proteomics, pharmacology, and informatics development. One also has unlimited opportunities to join as a teaching staff in public and private colleges and work in biomedical product manufacturing and scientific research institute and a lot more. For more information visit https://www.amity.edu

[cilected-blog]

Central approved to Bioanalytical Labs in India - lambda-cro

LAMBDA has absolutely GLP-compliant bioanalytical facility with the latest laboratories controlled by way of particularly skilled and experienced scientific experts and aid personnel.

All analytical strategies are evolved and tested in keeping with cutting-edge worldwide regulatory requirements with the assurance of precision recuperation and stability tests. Bioanalytical Labs in India

whilst all systems use tested software program that is compliant with all bioanalytical services making sure the highest of pleasant requirements and in compliance with hints. All information is electronically transferred and documented and all research is scrutinized through the QA branch and subjected to periodic in-residence audits to ensure compliance in LAMBDA cro.

LAMBDA bioanalytical workforce provides technical services to countrywide and worldwide Pharma agencies. Bioanalytical has the capacity to analyze >8000 samples in keeping with Month. Our bioanalytical group has a tested regulatory music report and regulatory compliant surroundings to meet regulatory and sponsor's pleasure. Best Bioanalytical Company

LAMBDA clinical studies afford bioanalytical services to support clinical studies. Our skilled scientists offer a full variety of LC/MS/MS bioanalytical offerings, from method development to method validation, Bioanalytical Labs in India and sample evaluation according to regulatory necessities. Our LCMSMS machines can examine samples with the use of more than one machine thereby reducing the general days of evaluation in some time-sure studies

•          method improvement and validation for a wide variety of drug substances

•          Quantitative analysis at picogram /mL concentrations

•          complex bioanalysis of sure and overall drug

•          Hormones and nutrition analysis. clinical data management company

Facility and Instrumentation:

Lambda facilities for bioanalysis unfolding over 3,000 sq. feet are ready with a tool lab and a pattern processing vicinity with contemporary abilities, a couple of equipment, and technology to make sure venture crowning glory with a quick-turnaround time. Late Phase clinical trials

The Bio-Analytical information is electronically transferred and stored on the Bioanalytical server. The server is backed up via mirroring on any other server.

•          ccess controlled Freezer room for sample garage has energy returned up and 24*7 temperature tracking and alarm machine, with -20°C Freezer and -eighty°C ULTF. Bioanalytical Labs in India

•          get admission to controlled entry and go out facility.

•          Separate sample processing laboratory.

•          LC-MS/MS laboratory.

•          ICP – MS (Perkins Elmer) laboratory.

•          high quit processing lab. clinical data management company

•          touchy machines like LC-MS/MS Shimadzu 8040, Shimadzu 8050 to reap the pg levels.

•          Analytical and Microbalance

•          stable section Extraction systems (forty eight properly plated)

•          Nitrogen Evaporators

•          Refrigerated Centrifuges

•          clever scan Temperature recording machine

•          Lab solution software program for LCMS/MS systems

[lizseyi]

Small Molecules: Method Development, Validation, And Transfer –Selvita

Development, optimization and qualification phases are crucial during the drug life cycle. At Selvita we work in efficient and flexible manner, using the best industry practices, in order to support our clients at this important process stage. Our team consists of industry experts with a thorough understanding of the process and long-standing professional expertise in the field, complemented by appreciation of the latest analytical and bioanalytical chemistry trends. 

We support our partners at various drug development stages, using a wide range of laboratory techniques. Starting from method development from scratch, method optimization via their full qualification under cGMP standards and batch release testing. Such activities are complemented with proven track record of successful method implementation within the Customers’ drugs life cycle in quality manner. 

Documentation provided upon each drug development step is based on templates available at Selvita or adapted to Customer’s requirements. We follow precisely the respective ICH guidance and general pharmacopeial requirements (methods and monographs); Customer’s methods and specifications, as well as internal procedures. 

In order to constantly monitor the process and discuss further action steps with the Client, we offer reoccurring teleconferences, showcasing project’s progress. 

Analytical and bioanalytical method development stage is utilized for medicinal product when there is no efficient method available for e.g., purity determination or assay; when the final product is a mixture of different active ingredients, or the existing method described in the guidelines is obsolete or does not meet Clients’ requirements. We check several crucial parameters at that stage, like specificity/selectivity, linearity, precision, accuracy/recovery, LOQ/LOD. The developed method is fully ready for the validation stage. 

For method development, we use either HPLC/UHPLC or GC(HS). Our analytical department is equipped with liquid chromatographs Agilent 1260 Infinity II and 1290 Infinity II (Agilent Technologies), Ultimate 3000 RS UHPLC and Ultimate 3000 SD HPLC (Thermo Fisher Scientific) with DAD-UV, PDA, FLD, CAD, ELSD, MS detectors, as well as headspace gas chromatographs with FID, MS detectors. 

There are some cases when methods exist and optimization is needed to meet the current standards and validation criteria. Selvita utilizes its professional expertise and experience gained while performing over 100 projects in various techniques and matrixes each year. 

Once the method is developed and optimized, it can be validated, which is mandatory action, if the method will be potentially used for testing drug product. Implementing a new method at analytical laboratory is crucial in the method’s life cycle, therefore it is performed under the laboratory management and quality assurance unit supervision. 

Validation is always conducted in line with approved protocols, consistent with ICH guidelines, which can be prepared either according to Selvita’s standard operating procedures (SOPs) or the client’s SOPs. Once the validation is complete, all results are described in validation report, which then should be approved by the Client. 

For the compendial methods or the method with validation status, method verification is performed. Method verification does not require formal protocols and can have limited range of parameters tested, otherwise, it is carried out in exactly the same way as validation. 

Method transfers from the company to another laboratory is also closely supervised. Transfers and methods validations are conducted according to the current cGMP regulations and approved protocols. 

All experiments required for such operations are conducted by our experienced analysts and supervised by the laboratory management. The forementioned guarantees that the (bio)analytical method works accurately and correctly in any workplace that is being implemented. 

[altasciences]

4 Things to Look for When Selecting a CRO/CDMO

When looking for a contract research organization (CRO) with CDMO pharma capabilities, there are certain features you should be aware of. How integrated are the teams? Does information flow freely from one team to the next, or are they stymied by handoffs and delays? What level of manufacturing do they offer? Your organization should address these questions before choosing a CRO/CDMO for your drug development cycle, so here are more details on the top factors to keep in mind.

How Integrated Is the CRO/CDMO? Ideally, all the teams of the CRO/CDMO would be fully integrated with each other. This might mean your organization is assigned a single manager who sees you through the entire drug development cycle, and that teams communicate easily. Find a CRO/CDMO that keeps a database of information that all teams can access, no matter what phase of the development cycle your drug is in. For example, the bioanalysis team would not have to wait for the clinical trial team to send over results, as they are already in the database. Bioanalytical services can start much sooner due to reduced wait times. Fully integrated CRO/CDMO services result in a smoother, streamlined drug development cycle overall. What Manufacturing Services Are Offered? If you are choosing a CRO with pharmaceutical CDMO capabilities, you are likely choosing it because the organization can take your drug development cycle from formulation to manufacturing, packaging to commercialization. This means you must ensure the CRO/CDMO has all the necessary capabilities. Can it manufacture your drug quickly for your clinical trial and to accommodate potential changes during the clinical trial? Can it perform nanomilling to increase the solubility of your drug? Can it fill vials, liquid-filled capsules, and/or powder-filled capsules? Find a CRO/CDMO that offers the areas of expertise you need to complete your drug development cycle, without needing an outside vendor. Does the CRO/CDMO Have Specialized Facilities and Equipment? Do they have custom-built Phase 1 clinical trial units? Do they have beds if you are planning to perform clinical trials with overnight components? Do they have specialized equipment, such as driving simulators for CNS clinical trials? It’s best to go with a CRO/CDMO that already has access to the resources you need because this effectively saves you time during clinical trials since you won’t have to use outside vendors. Can the CRO Recruit? What are the CRO’s recruiting capabilities? You will want to partner with a CRO that has an in-house team well-versed in marketing through multiple channels to reach the target population required for your trials. The ideal CRO will have a substantial database of healthy normal, patient, and special populations. This can greatly simplify recruiting as many are pre-screened and have shown interest in being part of clinical studies. About Altasciences As a mid-sized contract research organization and CDMO, Altasciences understands drug development is a complex process. The Altasciences team can help make the process smooth and streamlined for their partners. Altasciences is an integrated CRO with pharmaceutical CDMO services and more than 25 years of research experience. Pharmaceutical and biotechnology companies can count on the innovative, integrated approach Altasciences uses for preclinical studies and clinical trials, as well as bioanalysis, manufacturing, and analytical services. When your organization partners with Altasciences for clinical trials specifically, it gains the team’s expertise in a variety of therapeutic indications study types, including experience in first-in-human clinical trials and CNS clinical trials. The CRO/CDMO offers access to resources including highly trained and experienced staff, more than 580 beds, and a recruiting database of over 400,000 potential participants. Get the CRO/CDMO services you need with Altasciences at https://www.altasciences.com/ Original Source: https://bit.ly/3ByTEB8

[astuteinsights]

The exclusive report shares the future prospects, growth opportunities of the Analytical Standards Market by 2021-2027

Astute Analytica's recent study on the Analytical Standards Market provides a comprehensive review of the industry from 2021-2027.

In 2020, the global Analytical Standards Market valued at 1,432.7 Mn. The market is forecast to grow at a CAGR of 6.1% during the forecast period from 2021-2027.

This report includes an assessment of different factors that fuel the market's expansion. The market is transformed by trends, restraints, and drivers both positively and negatively as they affect the market. Additionally, this section provides a scope of the market by segment and application, which can potentially influence it in the future. This detailed information was compiled by analyzing current trends and historical milestones.

In the report, a detailed assessment of the restraints can be compared to their drivers and could be used to plan strategic activities. To grasp and benefit from the lucrative opportunities that are present in the ever-growing market, that need to understand the factors that impede the growth of the market. In addition, market experts' opinions were taken into consideration to gain a deeper understanding of the market.

An in-depth analysis is given of overall Analytical Standards Market growth prospects in this market study covering both the global and regional markets. The study also sheds light on the complete competitive landscape of the global Analytical Standards Market. In addition, the report provides a dashboard overview of leading companies regarding their marketing strategies, market contributions, and recent developments in both historic and present contexts.

It is important to consider a variety of factors when researching the market, from demographics and business cycles to microeconomic impacts specific to each country, the study found that market paradigms have evolved in terms of competitive advantage of regions and therefore major players' competitive landscape. Analysis of downstream demand and administration of upstream raw materials and equipment. In addition to providing key statistics on the state of the industry, this research also provides key guidance and direction for companies and individual market participants.

Covid-19 Impact on the Global Analytical Standards Market

Health problems have been reported in nearly every country due to the Covid-19 virus that was discovered in December. It has been declared a public health emergency by the World Health Organization. Coronavirus disease (Covid-19) is already having a significant global impact on the Analytical Standards Market, and this trend will continue into 2021. There have been more than 40 declarations of states of emergency because of Covid-19. The result has been canceled flights, travel bans, restaurants closing, events restricted, business confidence declining, and uncertainty about the future.

Regional Analysis: The Global Analytical Standards Market

A total of five regions were covered in the report: Asia Pacific, Europe, North America, Middle East & Africa, and South America. In this report, the United States, Germany, the United Kingdom, Japan, China, India, the United Arab Emirates, South Korea, South Africa, and Brazil are examined at the country level. The regional and country-level analyses in this report demonstrate the dynamic nature of some segments of the market, and how they differ from others.

Get our sample copy of the global Analytical Standards Market report that offers a brief introduction of the Analytical Standards industry, key players of the market, list of tables and figures and key countries & regions; Click: - https://www.astuteanalytica.com/request-sample/analytical-standards-market

Key Players: The Global Analytical Standards Market

In this report, an overview is provided of some of the market's most prominent players. The purpose of this study is to explore the importance of collaboration at competitive levels in foreign markets. 

The prominent players in the Global Analytical Standards Market are: 

 ●        Merck KGaA

●        Chiron AS

●        LGC Standards

●        Waters Corporation

●        Agilent Technologies

●        Thermo Fisher Scientific, Inc.

●        PerkinElmer, Inc.

●        Restek Corporation

●        SPEX Certi Prep

●        Accu Standard, Inc.

●        Mallinckrodt

●        US Pharmacopeial Convention

●        Cayman Chemical Company

●        RICCA Chemical Company and GFS Chemicals, Inc.

●        Other Prominent Players

Aim of the Report: The Global Analytical Standards Market

The global Analytical Standards Market is segmented based on By Category, By Technique, By Method, By Application. 

By Category

·  Organic

·  Inorganic

By Technique 

·  Chromatography

·  Spectroscopy

·  Titrimetry

By Method 

·  Material Testing

·  Bioanalytical

·  Dissolution 

By Application 

·  Pharmaceutical

·  Food & Beverages

·  Forensics

·  Environmental

Browse Some More Reports in The Healthcare industry:

Ophthalmic Devices Market Industry Dynamics, Forecast To 2027

Gene Therapy Market COVID Impact, Market Size, Top players- Novartis AG, Biogen

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us:

Phone number: +18884296757

Email: sales@astuteanalytica.com

Visit our website: https://www.astuteanalytica.com/

[nikitasavala]

Healthcare Analytical Testing Services Market 2021 | Covid19 Impact Analysis | Size, Share, Sales and Forecast to 2026: Eurofins Scientific, BioReliance, Anabiotec, Source BioScience, Charles River Laboratories, etc.

Global Healthcare Analytical Testing Services Market 2021 report is comprised of an in-depth analysis of the global industry which aims to deliver comprehensive market intelligence study associated with major market components. The report includes an overview of these markets on different fronts such as market size, market share, market penetration of the product and services, market downstream fields, key vendors operating within the territory, market price analysis and more. This might help readers across the worldwide business industry to comprehend a lot about the regional as well as key domestic markets for Healthcare Analytical Testing Services. Reports include an overview and examination of the major companies operating within the industry which are considered to be revenue drivers for the market.

Click Here To Get Free Sample Report or PDF Copy Now!

Top Key players of Healthcare Analytical Testing Services Market Covered In The Report: Eurofins Scientific BioReliance Anabiotec Source BioScience Charles River Laboratories Wuxi PharmaTech Almac Group PPD Exova Group Intertek Group Key Market Segmentation of Healthcare Analytical Testing Services: On the basis of types, the Healthcare Analytical Testing Services market from 2015 to 2025 is primarily split into: Bioanalytical Testing Services Physical Characterization Services Method Development and Validation Raw Material Testing Batch Release Testing Services Stability Testing Microbial Testing Environmental Monitoring On the basis of applications, the Healthcare Analytical Testing Services market from 2015 to 2025 covers: Pharmaceutical and Biopharmaceutical Companies Medical Device Companies Contract Research Organizations The Healthcare Analytical Testing Services report includes the study of these ventures on parameters such as market share, company profile, revenue figures, sales data, market presence, product or service portfolio, past performance, expected performance, and more. This may assist those who are willing to enhance their know-how of the competitive scenario of the Healthcare Analytical Testing Services Market.

Buy Latest Copy of Report! @ https://www.qurateresearch.com/report/buy/HnM/2020-2025-global-healthcare-analytical-testing-services-market/QBI-MR-HnM-989587/

Key Highlights from Healthcare Analytical Testing Services Market Study: Income and Sales Estimation – Historical Revenue and deals volume is displayed and supports information is triangulated with best down and base up ways to deal with figure finish market measure and to estimate conjecture numbers for key areas shrouded in the Healthcare Analytical Testing Services report alongside arranged and very much perceived Types and end-utilize industry. Moreover, macroeconomic factors and administrative procedures are discovered explanation in Healthcare Analytical Testing Services industry advancement and perceptive examination. Assembling Analysis – The Healthcare Analytical Testing Services report is presently broken down concerning different types and applications. The Healthcare Analytical Testing Services market gives a section featuring the assembling procedure examination approved by means of essential data gathered through Industry specialists and Key authorities of profiled organizations. Competition Analysis – Healthcare Analytical Testing Services Leading players have been considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit. Demand and Supply and Effectiveness – Healthcare Analytical Testing Services report moreover gives support, Production, Consumption and (Export and Import). Healthcare Analytical Testing Services Market Region Mainly Focusing: — Europe Healthcare Analytical Testing Services Market (Austria, France, Finland, Switzerland, Italy, Germany, Netherlands, Poland, Russia, Spain, Sweden, Turkey, UK), — Asia-Pacific and Australia Healthcare Analytical Testing Services Market (China, South Korea, Thailand, India, Vietnam, Malaysia, Indonesia, and Japan), — The Middle East and Africa Healthcare Analytical Testing Services Market (Saudi Arabia, South Africa, Egypt, Morocco, and Nigeria), — Latin America/South America Healthcare Analytical Testing Services Market (Brazil and Argentina), — North America Healthcare Analytical Testing Services Market (Canada, Mexico, and The USA) The Healthcare Analytical Testing Services Market report concludes with sharing vital report findings with readers. Here on the basis of study of historical data, examination of the current scenarios overserved in various markets including regional and domestic and trends recorded, it delivers forecast of the market. This includes segmental forecast, regional market forecast, market size forecast, consumption forecast.

Any query?Inquire Here For Discount Or Report Customization

Contact Us: Web:www.qurateresearch.com E-mail:sales@qurateresearch.com Ph: US - +13393375221 *Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. IKleos Space develops tool for in-space manufacturing of large structures NASA asks SpaceX to halt Lunar Lander exertion pending contract difficulties Raytheon receives a deal worth $228 million increase for GPS ground system DElon Musk on manufacturing Electric Cars: ‘Prototypes are Simple, Construction is Tough’ NASA captures picture of communication between doomed stars 15,000 light-years away Healthcare Analytical Testing Services, Healthcare Analytical Testing Services Market, COVID19 Impact on Healthcare Analytical Testing Services Market, Healthcare Analytical Testing Services Forecast, Healthcare Analytical Testing Services Market Growth, Healthcare Analytical Testing Services Market Sales, Healthcare Analytical Testing Services Market Size, Healthcare Analytical Testing Services Market Regional Analysis

[decisionforsight]

Global 3D Cell Culture Market

Global 3D Cell Culture Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

3D cell culture is a measured simulated environment outside of a living organism wherein cells are made to grow and migrate by interacting with their habitat. This process stimulates normal cell to differentiate, proliferate, and migrate by interacting with their three-dimensional surroundings. It provides an ideal environment for cell culture analytical studies, involving assessment of multi-stage disease models with the help of cellular modelling. This process is used by researchers to develop physiologically similar cell culture stereotypes that help in drug discovery and development. The increasing focus on developing an alternative to animal testing and growing emphasis on personalised medicine are the key drivers of this market. The global 3D cell culture market accounted 1432.5 USD Million in 2020 and is expected to reach 6319.3 USD million by 2030, witnessing an approximate CAGR of 16% over the forecast period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020140

Market Dynamics and Factors:

Growing investments in healthcare R&D by developed and developing countries, certain limitations of 2D cell culture techniques, and rising demands for organ transplantation are the major factors driving the growth of the 3D cell culture market across the globe. Additionally, 3D cell culture has the potential to completely substitute the use of animals in research and testing of pharmaceuticals. This will create lucrative opportunities for the market to grow in the future. However, lack of consistency of products and huge initial investment associated with the implementation of 3D cell culture are major factors that are restraining the market growth. Moreover, growing use of 3D cell culture in order to effectively examine the influence of drug doses will fuel the market growth in the future.

Market Segmentation:

Global 3D Cell Culture Market – By Product Type

Scaffold Based 3d Cell Culture

Microgels

Micro Patterned Surfaces

Solid Scaffolds

Scaffold Free 3d Cell Culture

Low Adhesion Micro Plates

3D Petri Dishes

3D Bioreactors

3D Hanging Drop Plates

 Microfluids Based 3D Cell Culture

Magnetic Leviation

3D Bio Printing

Global 3D Cell Culture Market – By Application

Drug Discovery & Toxicology

Cancer & Stem Cell Research

Tissue Engineering & Regenerative Medicine

Global 3D Cell Culture Market – By End-Users 

Pharmaceutical & Biotechnology Companies

Hospitals & Diagnostic Centers

Research Laboratories & Institutes

Global 3D Cell Culture Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020140 

Geographic Analysis:

North America is expected to dominate the market during the forecast period in terms of revenue market share. A robust & sophisticated healthcare infrastructure; high adoption of 3D cell cultures; increased emphasis on R&D by key market players; are the major factors attributing to the market dominance of the region. For instance, in 2018, InSphero AG announced a partnership with Path BioAnalytics with an aim to develop advanced 3D airway tissue model for cystic fibrosis research. Path BioAnalytics will develop and test 3D cystic fibrosis (CF) organoid models from primary human bronchial and nasal epithelial cells using InSphero’s exclusive 3D cell-based technology. This will assist in the formation of biologically-relevant and personalized organoids without the usage of artificial matrices. Europe is expected to be the second-most dominating market for the 3D cell culture during the forecast period. The growth in the pharmaceutical & biotechnology industry; growing presence of key market players; and a large number of R&D activities are the major factors attributing to the market growth in the European region. The Asia Pacific region is anticipated to be the fastest growing market for 3D cell culture during the forecast period. Rising demand in drug discovery and increasing focus on the biotechnology industry; and rising investments from the government and private companies in the APAC region are the major factors attributing towards the market growth.  

Competitive Scenario:

The key players operating in the global 3D cell culture market are –

Thermo Fisher Scientific, 3D Biomatrix, 3D Biotek LLC, Corning Technologies, Hamilton Company, Nano 3D Biosciences, Global Cell Solutions, Tecan Trading AG, Lonza Group Ltd., InSphero AG, Nanofiber Solutions.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020140 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global 3D Cell Culture industry, although key threats, opportunities and disruptive technologies that could shape the Global 3D Cell Culture Market supply and demand.

The report tracks the leading market players that will shape and impact the Global 3D Cell Culture Market most.

The data analysis present in the Global 3D Cell Culture Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global 3D Cell Culture Market business.

The 2021 Annual Global 3D Cell Culture Market offers:

100+ charts exploring and analysing the Global 3D Cell Culture Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global 3D Cell Culture Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020140 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[mandennews]

Global Healthcare Analytical Testing Services Market Forecasts, Insights to 2026 : EUROFINS SCIENTIFIC, LABCORP, SGS, CHARLES RIVER, WUXI PHARMATECH

Syndicate Market Research added the latest industry report that focuses on the Healthcare Analytical Testing Services market and gives a professional and in-depth Global Healthcare Analytical Testing Services market analysis and future prospects of market 2016-2026. This report offers a unique tool for evaluating the current market conditions also the competitive landscape, containing all-inclusive key players, product type, applications and crucial measurements for anticipating the development of the worldwide industry. The report starts with the review of the Industry environment and defines the industry chain structure, then summarises the industry size and forecast of the Healthcare Analytical Testing Services market between 2020-2026.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.syndicatemarketresearch.com/sample/healthcare-analytical-testing-services-market

This Healthcare Analytical Testing Services market report estimated at XX million USD in 2020 and is predicted to achieve XX million USD before the finish of 2026, with a CAGR of XX% during the years 2020 to 2026. North America is the biggest production and utilization region in the world, where China is the quickest developing country.

This report is totally evaluated to present a realistic vision with manufacturing value, income, sales revenue, market share and growth rate of every kind is mentioned. The study provides the prevailing market size of the Global Healthcare Analytical Testing Services Market and its growth rates on the basis of the last 5 years history records alongside the company profile of top players/producers such as (EUROFINS SCIENTIFIC, LABCORP, SGS, CHARLES RIVER, WUXI PHARMATECH, PHARMACEUTICAL PRODUCT DEVELOPMENT, EXOVA, PACE ANALYTICAL, ENVIGO, INTERTEK, MPI RESEARCH, MERCK KGAA, SOURCE BIOSCIENCE). The detailed statistics by segments of Healthcare Analytical Testing Services market support supervising future convenience & to settle on basic choices for development. The research also targets market materials, capacities as well as provides data on growth and trends, technologies, the CAPEX cycle and the dynamic structure of the global market.

Global Healthcare Analytical Testing Services market divided by Type such as (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials) and segmented by Application/end users (Pharmaceutical, Medical Device Companies) based on Gross Margin, Pricing, Sales Revenue (Million USD) of industry size & forecast with the help of their yearly functions and operations.

Enquire About COVID-19 Updates for This Report: https://www.syndicatemarketresearch.com/inquiry/healthcare-analytical-testing-services-market

This Report contains 15 Chapters to profoundly show the Global Healthcare Analytical Testing Services Market:

Chapter 1, to explain Introduction, market review, market risk and opportunities, market driving force, product scope of Healthcare Analytical Testing Services Market; Chapter 2, to inspect the leading manufacturers (Cost Structure, Raw Material) with sales Analysis, revenue Analysis, and price Analysis of Healthcare Analytical Testing Services Market; Chapter 3, to show the focused circumstance among the best producers, with deals, income, and Healthcare Analytical Testing Services market share in 2016 and 2018; Chapter 4, to display the regional analysis of Global Healthcare Analytical Testing Services Market with revenue and sales of an industry, from 2019 to 2026; Chapter 5, 6, 7, to analyze the key countries (United States, China, Europe, Japan, Korea & Taiwan), with sales, revenue and market share in key regions; Chapter 8 and 9, to display Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis; Chapter 10 and 11, to analyze the market by product type and application/end users (industry sales, share, and growth rate) from 2016 to 2018; Chapter 12, to show Healthcare Analytical Testing Services Market forecast by regions, forecast by type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials) and forecast by application (Pharmaceutical, Medical Device Companies) with revenue and sales, from 2019 to 2026; Chapter 13, 14 & 15, specify Research Findings and Conclusion, Appendix, methodology and data source of Healthcare Analytical Testing Services market buyers, merchants, dealers, sales channel.

Geographically, This Healthcare Analytical Testing Services Market report accommodates regional Output, production, consumption, revenue (million USD), growth rate (CAGR) by Countries such as North America (United States, Canada, Mexico), South America (Argentina, Brazil, Ecuador, Chile), Europe (UK, France, Germany, Italy), Middle East, Africa (Turkey, Egypt, Saudi Arabia, Iran), Asia-Pacific (India, China, Japan, Korea) and more which are forecasts during 2016-2026.

This Research Study Offers :

�� Future funding possibilities in the Healthcare Analytical Testing Services market investigating value patterns. • The market development and forecasts for a minimum of 5 years of all the mentioned regional markets • The Market openings and capable hazards related to Healthcare Analytical Testing Services industry by evaluating trends. • Key factors that will impact development, containing future income projections. • The unique organizations with portfolios and current improvement in the Healthcare Analytical Testing Services industry until 2026. • Essential research and development elements and information experiences to chargeable for developing the market percentage.

To get more information on this Premium Report, Click Here @ https://www.syndicatemarketresearch.com/market-analysis/healthcare-analytical-testing-services-market.html

In conclusion, Global Healthcare Analytical Testing Services Market Report helps to describe the synopsis of all merchandise evolved in granular detail, with the significant perception of most recent innovations and milestones like companies presently performing in the market around the world. With the last 5 years' income figure the report gives a huge proposition for people and organizations about modern business investment opportunities of Healthcare Analytical Testing Services market before evaluating its possibility.

Note – In order to provide a more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19. (*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Syndicate Market Research:

At Syndicate Market Research, we provide reports about a range of industries such as healthcare & pharma, automotive, IT, insurance, security, packaging, electronics & semiconductors, medical devices, food & beverage, software & services, manufacturing & construction, defense & aerospace, agriculture, consumer goods & retailing, and so on. Every aspect of the market is covered in the report along with its regional data. Syndicate Market Research committed to the requirements of our clients, offering tailored solutions best suitable for strategy development and execution to get substantial results. Above this, we will be available for our clients 24×7.

Contact Us:

Syndicate Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States +1 347 535 0815 | Email ID: sales@syndicatemarketresearch.com Website: www.syndicatemarketresearch.com  | Blog: Syndicate Market Research Blog

[lambdatherapeutic]

bioequivalence studies

[avajones]

Contract Research Outsourcing Market Share & Analysis, By Product Type, By End Use, Forecasts to 2026

The Global Contract Research Outsourcing Market report gives a comprehensive overview of the Contract Research Outsourcing market scenario to present accurate forecasts of the upcoming years with special focus on the competitive landscape, market segmentation, current and emerging trends, and strategic recommendations to help readers gain a robust footing in the market. The report also focuses on the comprehensive analysis of the competitive landscape along with descriptive company profiles, market share, product portfolio, financial standings, market reach, global position, and strategic business expansion plans. Market Size – USD 38.18 Billion in 2018, Market Growth - CAGR of 7.4%, Market Trends – Product launches and research for advanced Contract Research Outsourcing Market

The report is furnished with the latest market scenario pertaining to the COVID-19 pandemic and its after-effects on the Contract Research Outsourcing industry and the key segments. The pandemic has disrupted the workflow of the industry and created financial difficulties. The report assesses the complete impact of the pandemic on the market and offers key insights into the market scenario along with trends and demands disruptions. The report also offers an outlook on the market scenario in the forecast timeline.

Get the sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1846

Some of the players profiled in the report are Charles River Laboratories, Parexel International, IQVIA, Covance, PRA Health Sciences, LabCorp, Pharmaceutical Product Development (PPD), Clinitec, ICON plc, Medidata Solutions, and EPS International.

The Global Contract Research Outsourcing Market is segmented as follows:

Product Type (Revenue, USD Million; 2016–2026)

Early Phase Development Services

Clinic Research Services (CRS)

Laboratory Services

Physical Characterization

Toxicology Testing

Stability Testing

Raw Material Testing

Other Analytical Testing

Consulting Services

Pharmacokinetics/Pharmacodynamics (PK/PD)

Batch Release Testing

Others

Discovery Studies

Chemistry, Manufacturing & Control (CMC)

Preclinical Services

Phase I CRS

Phase II CRS

Phase III CRS

Phase IV CRS

Bioanalytical Testing

Analytical Testing

Therapeutic Area Type (Revenue, USD Million; 2016–2026)

Oncology

Immunological Disorders

Central nervous system (CNS) Disorders

Cardiovascular Diseases

Infectious Diseases

Respiratory Disorders

Diabetes

Other

End Use (Revenue, USD Million; 2016–2026)

Pharmaceutical and Biopharmaceutical Companies

Medical Device Companies

Academic Institutes

Others

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1846

Market Segmentation by Regions:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Point Summary of the Report:

The global Contract Research Outsourcing market research report is an investigative study offering key insights into the latest growth trends, developments, technological and product advancements, and the research and development scenario. The report also covers the market aspects that directly influence the growth of the market. These features include strategies undertaken by the prominent players, their expansion tactics, and the product portfolios of the companies, and micro and macro-economic factors.

Access complete report description, toc, chart, etc.@ https://www.reportsanddata.com/report-detail/contract-research-outsourcing-market

The study also analyses the crucial market aspects, including R&D, product launches and brand promotions, mergers and acquisitions, collaborations, joint ventures, and the growth pattern on both regional and global levels. The report offers an in-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends.

The Global Contract Research Outsourcing Market includes relevant and verified information relating to the overall market, key players, and their market position and financial standing. The report utilizes advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, investment return analysis, and feasibility analysis to offer a comprehensive view of the market position of the major players of the industry.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1846

To summarize everything stated above, the report offers key insights into the Contract Research Outsourcing market to allow the reader to gain a complete understanding of the Global Contract Research Outsourcing Market through accurate estimations, a panoramic view of the market scenario, competitive landscape, factors influencing the growth of the market, driving factors, restraints, regulatory framework, growth prospects and opportunities, and factors propelling the market forward. The research study offers an in-depth view of the industry to offer a competitive edge to the reader and help them in formulating beneficial investment plans. The report provides a comprehensive overview of the market with facts relating to the past, present, and future of the Global Contract Research Outsourcing Market.

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or queries about customization options, please reach out to us, and we will offer you the report best suited for your needs.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W Head of Business Development Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Reports  and Data | Web: www.reportsanddata.com News: www.reportsanddata.com/market-news Connect with us:  Facebook | Google+ | LinkedIn | Twitter

[amitynoida]

Amity University: Leading Among the Colleges Providing B.Sc. Bioinformatics Course in Noida

B.Sc. Bioinformatics is a modern, interdisciplinary field of education that seeks to curate methods and online tools for understanding biological data, particularly in large data sets. It is a concept that combines biology, physics, chemistry, computer science, mathematics, statistics, and information engineering.

Amity Noida is on a lead among the best university that are providing B.Sc. Bioinformatics course in Noida. Designed in accordance with international standards the course focuses on proving a comprehensive approach to its learners on developing modern medicines and new agricultural products. Being among the best Bioinformatics colleges in Delhi NCR the university focuses its applications in genome profiling, genome sequencing, and protein expression analysis.

Infrastructure

Amity University is equipped with 100 Mbps Wi-Fi at every corner, computer labs, libraries, CCTV coverage all around the campus, audio-visual facilities, A/C classrooms, a high-end conference hall, printing facilities, all possible lab facilities for the B.Sc. students with the faculty support and practical exposure.

Amity:  Best Bioinformatics University in Delhi NCR

Amity University is one of the best Bioinformatics colleges in Delhi NCR. It aims to increase the student's understanding of Biological Processes. Bioinformatics is mainly used to extract knowledge from biological data through the development of algorithms and software. It is widely applied in the examination of Genomics, Proteomics, 3D structures modeling of proteins, image analysis, drug designing, and a lot more.

Duration and Eligibility

The duration of B.Sc. Bioinformatics course at Amity University is 4 years and the students who have scored 60% in 10th standard and 12th standard and 60% in PCM/PCB are eligible to apply for the course.

Career Opportunities

Amity being among the best Bioinformatics colleges in Delhi NCR understands the need of the hour and the importance of growth in the scientific field offering promising career opportunities. The university provides campus placements where students can work in leading IT companies. Candidates can pursue careers in computational chemistry, bioanalytics, database design and maintenance, proteomics, pharmacology, and informatics development. One also has unlimited opportunities to join as a teaching staff in public and private colleges and work in biomedical product manufacturing and scientific research institute and a lot more. For more information visit https://www.amity.edu

​​​​​​​Source : https://amityuniversitydelhincr.blogspot.com/2023/08/amity-university-leading-among-colleges.html

[ericvick]

Billionaire David Shaw Bets Big on These 3 Healthcare Stocks

The last few months have seen high volatility and a rising market trend, as one of the biggest sources of uncertainty – namely, the election campaign – has worked itself out.

The current political climate is viewed as favorable for healthcare investment – tax increases and further regulations on drug price, anticipated before the elections, when prognosticators expected the Democrats to ride a ‘blue wave’ to an across-the-board victory, are now seen as unlikely under a government with close partisan divisions.

In light of the new conditions, Goldman Sachs strategist David Kostin has upgraded his stance on the healthcare sector from underweight to overweight.

Kostin is recommending healthcare stocks as the value-end of a diversified portfolio strategy. He points out that the sector is up 6% in the past month, but adds that it is still priced at bargain levels, saying, “Healthcare is the best opportunity from a value perspective. They’re the cheapest they’ve been, so that’s an area of focus.”

But how are investors supposed to distinguish between the long-term healthcare winners and those set to come up short? One strategy is to follow the activity of the pros.

Enter David Shaw, who is widely known for his impressive stock picking abilities. Shaw’s name is familiar to followers of quantitative trading. He helped develop the techniques in the late 80s, and his early mastery of quant helped him grow his firm, D. E. Shaw, into an $82 billion giant of the hedge industry. While most of D.E. Shaw’s day-to-day operations are now managed by the Executive Committee, Shaw still remains involved in higher-level strategic decisions.

Bearing this in mind, we decided to look at D. E. Shaw’s recent activity for inspiration. Running three healthcare stocks the fund picked up during Q3 through TipRanks’ database, we found out that the analyst community is also on board, as each sports a “Strong Buy” consensus rating.

Vertex Pharmaceuticals (VRTX)

Story continues

First up is Vertex Pharmaceuticals, a Boston-based company that got its start creating medications for patients with cystic fibrosis, a serious, and usually fatal, genetic lung disease. Vertex currently has four approved CF treatments on the market, along with an active research pipeline focusing on drugs to treat rare genetic disorders. Vertex’s strategy is to develop medications that will treat or ameliorate the underlying genetic mutation of such diseases, rather than suppress symptoms. The company has treatments under development for a varied range of conditions, including sickle cell disease, beta thalassemia, and Duchenne muscular dystrophy.

The Company had a strong financial performance in Q3, generating $1.54 billion, up 62% year-over-year. The EPS came in at $2.64, beating the forecast by 10.5%.

But not everything has gone as planned. The company announced in October that it would discontinue work on the Phase 2 study of VX-814, the prime drug in its pulmonary research pipeline, due to safety concerns. The move pushed the shares down 20%, and they still have not recovered.

Things make an interesting background to Shaw’s recent purchases. The fund bought 203,308 shares of VRTX in Q3. At current prices, this is worth $46.8 million. It’s important to remember that Shaw made these purchases before the VX-814 news broke.

Covering Vertex for Piper Sandler is 5-star analyst Edward Tenthoff, who writes of the stock, “While VX-814 for alpha-1 antitrypsin deficiency (AATD) discontinuation was disappointing, we think sell-off in VRTX shares was overdone. Follow-on VX-864 has initiated Phase II study, with distinct structure, that may alleviate VX-814’s scaffold mediated liver toxicity with data expected in 1H:21. Additionally, Phase II study of VX-147 in FSGS is enrolling with data expected in 2021.”

To this end, Tenthoff rates VRTX an Overweight (i.e. Buy). He sets a $307 price target that implies a 33% upside potential for the next 12 months. (To watch Tenthoff’s track record, click here)

Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth in the year ahead. (See VRTX stock analysis on TipRanks)

Cigna Corporation (CI)

Cigna is one of the biggest names in the healthcare insurance industry. Subsidiaries of the Connecticut-based company provide a range of medical, dental, disability and other related insurance products, and the company is a major provider of both Medicare and Medicaid plans. Cigna boasted over $153 billion total revenue for calendar year 2019.

The company is on track, this year, to exceed the 2019 revenues. The Q1 top line came in at $38 billion, and revenues have grown since then. For the third quarter, the result came in at $41 billion, while EPS came in at $4.41. EPS has come in above expectations for 7 quarters in a row. The results show the quality of a major medical insurer at a time of global health crises.

Among the fans is David Shaw. 782,737 shares were bought up by D. E. Shaw in Q3, with the total position now landing at 804,425 shares. The position is valued at $168 million.

Deutsche Bank analyst George Hill covers Cigna, and he is also impressed by what he sees. Of the company’s current position, he writes, “Cigna saw a quarterly uptick in medical utilization—a trend the company believes will persist into the back-half of the year and into FY21, likely resulting in more normalized MLR trends.”

“We continue to see Cigna as one of the most attractive growth stories in the MCO space trading at a compelling valuation, though we concede that investor pessimism regarding the commercial insurance space could prevent the shares multiple from expanding in the near to medium term,” the analyst concluded.

In line with these comments, Hill rates CI shares as a Buy along with a $280 price target. This figure indicates confidence in 34% upside growth for 2021. (To watch Hill’s track record, click here)

Overall, the 14 recent reviews on Cigna break down to 13 Buys and 1 Hold, making the analyst consensus rating a Strong Buy. The stock is selling for $209.35, and the $255.57 average price target suggests a 22% upside from that level. (See CI stock analysis on TipRanks)

Syneos Health (SYNH)

Last but not least is Syneos, a contract research organization that bills itself as offering biopharmaceutical solutions. Syneos’ services include bioanalytics, clinical development, commercialization, diagnostics, and medical devices. The company serves a global customer base, helping research companies conduct late-stage clinical trials. Syneos offers the multidimensional expertise that focused biopharms won’t necessarily have.

The value of the niche can be seen from the revenues and earnings — Syneos regularly tops $1 billion in revenue per quarter; the recent Q3 result was $1.1 billion. EPS has been climbing since the first quarter, when the corona crisis hit the economy, and the third quarter earnings, at 93 cents per share, beat the forecast by 17%. The year-over-year EPS growth was stronger, at 20%.

Quant expert Shaw is clearly impressed by SYNH, enough to buy an additional 164,135 shares, nearly doubling his holding in the stock. Shaw’s current stock ownership in Syneos is worth $21.9 million.

Reviewing Syneos for JPMorgan, 5-star analyst Tycho Peterson says, “We expect the company to outgrow industry peers aided by a diversified global footprint and therapeutic expertise in high-growth segments within clinical development including CNS, oncology, and complex diseases over the next several years. As such, we see room for upside from current levels as SYNH continues to generate revenue and earnings growth above industry averages.”

Peterson backs his comments with an Overweight (i.e. Buy) rating, and an $85 price target that suggests the stock has room to grow 30% over the next year. (To watch Peterson’s track record, click here)

All in all, Syneos gets a Strong Buy rating from the analyst consensus. The rating is supported by 6 Buys and 1 Hold. The average price target, of $78.57, implies an upside potential of 20% from the current trading price of $65.65. (See SYNH stock analysis on TipRanks)

To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

[altasciences]

How CROs Ensure Reliable Study Results with Robust Sample Management

If you hope to get reliable, robust data from clinical trials to better inform decision-making, your CRO will need proper handling of specimens obtained from trial participants and samples prepared for lab analysis. Their precise, timely treatment is vital to making go/no-go decisions for a new therapeutic drug. There must be a certainty to the data that comes from proper handling to give the highest accuracy of results to inform decisions. The quality of data depends on rigorous sample management. Integrity needs to be safeguarded at every step.

A CRO partner conducting preclinical and clinical studies and providing bioanalytical services must ensure continuity of processes, knowledge sharing, and long-term storage of samples in a centralized location. Here is everything you need to know about choosing the right CRO for your sample management needs. Proper Collection and Storage Conditions There are many different sample types across preclinical studies and clinical trials. The CRO will need a variety of storage containers set at proper temperatures to ensure the integrity of the samples. Stabilizers, anticoagulants, and other preservatives may be necessary. The CRO should have a comprehensive sample collection manual detailing the requirements, ensuring that study personnel are well informed. The CRO should also be flexible to accommodate study variables. Standardizing Workflows Improves Risk Management and Chain of Custody To minimize potential risks to sample integrity or breaks in the chain of custody, the CRO should have consistent, standardized workflows. An electronic data capture system at the clinical site can help ensure complete data entry. This decreases erroneous identification of clinical samples or mislabeling. An EDC system can also track all relevant information for specimens, accounting for them as they move from collection to transport and lab analysis before going into storage. A laboratory informatics management system should be used in a bioanalytical laboratory to ensure chain of custody and traceability. Understanding Environmental Conditions with Stability Testing Stability testing is needed to understand which samples will remain viable when tested against certain environmental conditions, such as time, humidity, temperature, agitation, evaporation, and light. Shelf-life stability in those conditions should be determined and maintained. Short-term and long-term stability are both important. Laboratory Management for Keeping Data Organized Clinical samples are entered into the LIMS at the bioanalytical site according to labeling and documentation provided by the clinical site. Each sample tube will be assigned a barcode if the clinical site uses an EDC. The LIMS will use that barcode. This makes it much easier to manage than manually prepared documentation. It helps immediately identify any discrepancies. Managing Bioanalytics You will need a comprehensive sample management program that can handle a wide variety of matrices for bioanalysis. It will require robust method development and validation expertise. The laboratory must have exhaustive procurement procedures, as well as an in-house inventory of matrices available for validation, stability testing, sample analysis, and method development. This can be important for later phases, such as when it comes to CDMO pharma services, especially when determining the best method for delivery. About Altasciences Altasciences, a mid-sized contract research organization, knows drug development can be a complex process. The Altasciences team can make your organization’s next drug development project smooth and streamlined. As an integrated CRO with pharmaceutical CDMO capabilities, Altasciences offers partners over 25 years of research experience. Many pharmaceutical and biotechnology companies have come to rely on Altasciences’ innovative, integrated approach for preclinical studies, clinical trials, bioanalysis, and formulation and manufacturing. Partnering with Altasciences means gaining their team’s expertise in various therapeutic indications and study types. This includes valuable experience in first-in-human clinical trials and CNS clinical trials. Best of all, the CRO/CDMO offers clinical trial partners access to a wide variety of resources, including more than 580 beds, a highly trained and experienced staff, and a recruiting database of over 400,000 potential participants. Partner with Altasciences for reliable data at https://www.altasciences.com/ Original Source: https://bit.ly/3ydoUCo